Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR

Breast tumors lacking expression of human epidermal growth factor receptor 2 (HER2) and the estrogen and the progesterone receptors (triple negative; TNBC) are more aggressive than other disease subtypes, and no molecular targeted agents are currently available for their treatment. Because TNBC comm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ferraro, Daniela A., Gaborit, Nadège, Maron, Ruth, Cohen-Dvashi, Hadas, Porat, Ziv, Pareja, Fresia, Lavi, Sara, Lindzen, Moshit, Ben-Chetrit, Nir, Sela, Michael, Yarden, Yosef
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2013
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3562774/
https://ncbi.nlm.nih.gov/pubmed/23319610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1220763110
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados